Prognostic value of serum tumor abnormal protein in gastric cancer patients

被引：55

作者：

Lan, Feng ^{[1
]}

Zhu, Ming ^{[1
]}

Qi, Qiufeng ^{[1
]}

Zhang, Yaping ^{[1
]}

Liu, Yongping ^{[1
]}

机构：

[1] Soochow Univ, Changzhou Tumor Hosp, Clin Oncol Lab, 1 Huaide Rd, Changzhou 213000, Jiangsu, Peoples R China

来源：

MOLECULAR AND CLINICAL ONCOLOGY | 2016年 / 5卷 / 01期

关键词：

tumor abnormal protein; gastric cancer; sensitivity; prognosis; tumor-node-metastasis stage;

D O I：

10.3892/mco.2016.877

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Aberrant glycosylation of protein occurs in nearly all types of cancers and has been confirmed to be associated with tumor progression, metastasis and the survival rate of patients. The present study aimed to explore the prognostic value of tumor abnormal protein (TAP) in gastric cancer patients. TAP was detected in the blood of 42 gastric cancer patients and 56 healthy volunteers by using the TAP testing kit. Univariate and multivariate Cox regression analysis were performed to evaluate the prognostic value of TAP. In total, 64.3% of gastric cancer patients were positive for TAP, and TAP was significantly correlated with poor prognosis [progression-free survival (PFS), 4.2 vs. 12.6 months; P=0.043]. TAP [hazard ratio (HR), 64.487; P<0.01), differentiation (HR, 17.279; P<0.01) and TNM stage (HR, 45.480; P<0.01) were found to be independent predictive factors for PFS. Furthermore, Kaplan-Meier curves indicated that TAP is associated with a reduced PFS in gastric cancer patients. The results of the present study therefore indicated that the TAP test has significant prognostic value for gastric cancer patients.

引用

页码：216 / 220

页数：5

共 31 条

[1]

Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) [J].